top of page
  • LinkedIn
  • Twitter
  • Instagram

Mark J. Field PhD MSc FRSB

Neuroscientist

30 years pharma experience to Head of R&D

Creating Personalized Analgesics®

ICONS
image0 (8).jpeg

ABOUT

image4.jpeg

PROJECTS

image5.jpeg

RESEARCH

image1 (2).jpeg

CONTACT

About
image0 (8).jpeg

ABOUT

Back to Icons

Find out more about Analgesic Innovation (Ai)

Entrepreneur scientist with over 30 years’ experience developing new medicines in Neuroscience & Pain.

 

Unique expertise across both preclinical research & clinical development @ Pfizer, Parke-Davis, MSD & Grunenthal. 

 

Currently CEO & Founder of Eptiva Therapeutics Ltd and Founder/Owner of Analgesic Innovation (Ai).

Find out more about Eptiva Therapeutics

Transparent.png
Projects
image4.jpeg

PROJECTS

Back to Icons

Find out more about 

Personalized Analgesics®

Led the research that identified Gabapentin (Neurontin®) and Pregabalin (Lyrica®) as analgesics which generated peak annual revenues of over $5 Billion for Pfizer.

​

Associated with >30 compounds entering clinical trials.

​

Created a novel Personalized Analgesics® a bioinformatic network biology technology platform to link research targets to disease and de-risk pain R&D. This will help move much needed treatments closer to patients.

Research
image5.jpeg

RESEARCH

Back to Icons

Explore MyBlog 

for expert views on analgesic news

PhD and MSc degrees from Portsmouth University and Kings College London. My Research is documented in over 100 full-length Manuscripts, Abstracts and Patents with over 5000 citations and h-index of 34. Link to published research.

​

Independent R&D/analgesic expert - International speaker.

Contact
image1 (2).jpeg

CONTACT

Back to Icons

Contact me here

or on social media.

  • LinkedIn
  • Twitter

Float back to top

©2020-2023 markjfield.com

bottom of page